Velvet Rx NAD+ is useful to examine because a commercial offer can answer one question while leaving another open. A displayed price tells us what the seller advertises; it does not tell us whether a finished preparation produces a meaningful health benefit. We follow those two threads separately in this review.
Our review uses public provider documents and primary scientific or regulatory references. We have not ordered Velvet Rx NAD+, sampled its contents or measured results in patients. Read the documented details below as a starting point for a more specific conversation, with the unknowns left visible rather than replaced by a score.
THE USEFUL DISTINCTION
Use the selected written proposal to connect the product, the people responsible for care, and the payment commitment. An unresolved blank is a question to answer before deciding.
What the current documents establish
The NAD+ injection card still advertises “as low as $89”; quantity and billing period remain unestablished. General terms allow recurring charges for selected subscriptions, checkout-defined intervals, cancellation before a charge, and possible payment before onboarding finishes. Separate fees may apply. Processed or discounted orders may be nonrefundable, subject to law. These are conditional terms, not proof that every NAD order renews monthly. The named platform and pharmacy partners do not establish the team for your order. Neither nationwide NAD access nor GLP-1 package inclusions are established for this purchase. The separately referenced refund policy was not available through a link in the captured terms.
We refreshed the public storefront and general agreement on November 7, 2026. We did not enter an account, submit intake, complete checkout, seek a refund, contact support or test a preparation. The graphic below retains its October 12 snapshot. Older federal references later in this review were unavailable for a fresh check; their retained discussion is historical, not a newly verified policy update.
Read the offer at a glance
- NAD headline: As low as $89
- Billing period: Not established by the homepage card
- Renewal: Recurring-service terms apply when a subscription is selected
These are the published terms for Velvet Rx NAD+ as checked on October 12, 2026. The graphic keeps the offer's own units and conditions; it is not a comparison of clinical effectiveness. A missing specification or fee has not been treated as zero.
Evidence: Velvet Rx: NAD+, sermorelin and GHK-Cu offers / Velvet Rx: terms of use and recurring billing
Build one record for the selected purchase
Start a document record for the exact proposal you are considering. Save its date and the product name as written, then keep the proposal beside the page you first read. The purpose is to make the decision traceable: someone else should be able to see which statement you relied on, where it appeared, and which question was still open. Do not fill a blank with a detail from an unrelated offer.
Use three simple status labels in your notes: stated in the selected document, confirmed in a written response, and still unanswered. These are labels for your evidence, not quality ratings for the seller. If two documents disagree, preserve both versions and ask which governs the proposed order. Record the answer alongside them instead of deleting the earlier wording. That gives you a usable record even if the proposal changes before you decide.
Evidence: Offer
Separate the decisions in the payment timeline
Before authorizing payment, draw a short timeline with an assessment decision, a payment decision and any later order decision. These are prompts for obtaining the actual terms; they do not assume a particular sequence for this purchase. Ask which event authorizes a charge and which event commits you to a preparation. Write the response in the seller’s stated units and dates rather than converting an incomplete quote into a monthly estimate.
Then work through two hypothetical administrative situations: you decide not to proceed, or an assessment does not produce the proposal you expected. Ask for a written explanation of which charges, if any, remain due in each situation. Do not treat an unanswered refund question as either a promise of reimbursement or a conclusion that nothing is refundable. Keep the cancellation instruction and the contact destination with the selected agreement, so the information can be used if needed.
Evidence: Agreement
Compare the documents before comparing value
This worksheet deliberately contains no estimated amounts. Complete it from the documents for the proposed purchase, and use the last column for questions requiring a written answer. A blank cell means the information has not been entered; it does not mean zero cost, no obligation, or a service that is included. Keep the measurement unit with any quantity and the stated time period with any payment.
Once the fields are complete, compare like with like. Decide which items belong to the same proposed commitment before adding them together. If you cannot establish that they refer to the same product and period, retain separate subtotals and describe the unresolved difference. The cost explainer provides context for organizing the comparison; it cannot supply the missing details of this order.
| Question to resolve | Selected proposal | Written confirmation | Still unanswered |
|---|---|---|---|
| Exact product and route | |||
| Quantity and stated units | |||
| Total due at the decision point | |||
| Any later commitment and its period | |||
| Who is responsible for each charge | |||
| How to stop a later order | |||
| What happens if you do not proceed | |||
| Documents and dates supporting the answer |
Evidence: Agreement
Put a name beside each responsibility
Prepare a short responsibility list for the care conversation. Who evaluates the request, who answers questions about the proposed preparation, and who handles a payment discrepancy? These questions are our suggested way to organize the conversation, not a claim that we tested those services. Ask for the legal name and role attached to each answer, and retain the contact details with the corresponding document.
A useful reply should address your selected proposal rather than repeat a general promise. If the answer does not resolve the question, restate the missing detail and ask which person can clarify it. Do not convert a role description into an independent assessment of skill, product quality, response time or suitability. We have not performed those assessments. Our injection-specific review separates the preparation questions from this provider-level document review and retains its own historical check date.
Evidence: Agreement
What would count as useful evidence
NAD+ participates in normal cellular metabolism. That fact explains scientific interest, but it does not establish that Velvet Rx NAD+ improves energy, cognition, recovery or longevity. Evidence from a different ingredient or route has to be identified as such. Where a compounded drug is offered, it is not FDA-approved; a pharmacy credential does not change the approval status of the finished preparation.
Look for a match between the research and the proposed product. The ingredient, route, studied population, comparison group and measured outcome all matter. For Velvet Rx NAD+, a change in a laboratory marker would answer a narrower question than improved everyday function. A story about feeling better cannot show what would have happened without treatment. Ask the clinician which finding actually supports the intended purpose and what remains uncertain.
Evidence: Velvet Rx: NAD+, sermorelin and GHK-Cu offers / Velvet Rx: terms of use and recurring billing / FDA: Compounding questions and answers / NIH Office of Dietary Supplements: Niacin
Bring the evidence and the proposal to the same conversation
Finish with two short lists: the outcome you want to discuss with a clinician, and the unresolved details of the proposed purchase. Ask the clinician to explain the relevant evidence in relation to that proposal, including where the evidence does not match. The molecule explainer offers a reading exercise; the route comparison and safety guide provide further questions to bring.
This review does not turn the completed worksheet into a recommendation. Its purpose is to help you identify a decision you can actually evaluate, with the uncertainties still attached. The featured paid placement elsewhere on this page remains a commercial arrangement; it does not change the questions to ask of this offer.
Evidence: Agreement
Open the source material
- Offer
Public document; checked November 7, 2026.
- Agreement
Public document; checked November 7, 2026.
- Velvet Rx: NAD+, sermorelin and GHK-Cu offers
Provider statement, not independent verification of outcomes. Offer checked October 12, 2026.
- Velvet Rx: terms of use and recurring billing
Provider statement, not independent verification of outcomes. Offer checked October 12, 2026.
- FDA: Compounding questions and answers
Primary reference; does not endorse the reviewed provider.
- NIH Office of Dietary Supplements: Niacin
Background on NAD and related nutrition; not a trial of this offer.
